BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25838421)

  • 1. High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.
    Agarwala AP; Rodrigues A; Risman M; McCoy M; Trindade K; Qu L; Cuchel M; Billheimer J; Rader DJ
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1515-9. PubMed ID: 25838421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
    Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
    Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
    Hafiane A; Jabor B; Ruel I; Ling J; Genest J
    Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected?
    Uzunlulu M; Oğuz A; Tigen K
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):268-70. PubMed ID: 16330390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
    Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
    Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis.
    Saku K; Zhang B; Ohta T; Arakawa K
    J Am Coll Cardiol; 1999 Feb; 33(2):436-43. PubMed ID: 9973024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans.
    Arsenault BJ; Dubé MP; Brodeur MR; de Oliveira Moraes AB; Lavoie V; Kernaleguen AE; Guauque-Olarte S; Mathieu P; Pibarot P; Messika-Zeitoun D; Bossé Y; Rhainds D; Rhéaume E; Tardif JC
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):457-62. PubMed ID: 24334872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level.
    Paavola T; Kuusisto S; Jauhiainen M; Kakko S; Kangas-Kontio T; Metso J; Soininen P; Ala-Korpela M; Bloigu R; Hannuksela ML; Savolainen MJ; Salonurmi T
    PLoS One; 2017; 12(2):e0171993. PubMed ID: 28207870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of non-HDL cholesterol with the presence of metabolic syndrome in North Indian subjects with and without CAD.
    Garg PR; Kabita S; Sinha E; Kalla L; Kaur L; Saraswathy KN
    Ann Hum Biol; 2013 Jan; 40(1):111-5. PubMed ID: 23198906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity.
    Luo M; Liu A; Wang S; Wang T; Hu D; Wu S; Peng D
    Sci Rep; 2017 May; 7(1):2312. PubMed ID: 28539597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of high-density lipoprotein cholesterol predict the presence of coronary artery disease in patients with aortic aneurysms.
    Saigusa T; Izawa A; Miura T; Ebisawa S; Shiba Y; Miyashita Y; Tomita T; Koyama J; Fukui D; Takano T; Amano J; Ikeda U
    Angiology; 2014 Sep; 65(8):710-5. PubMed ID: 24019083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoproteins and coronary artery disease: a single-center cohort study.
    Schaffer A; Verdoia M; Barbieri L; Aprami TM; Suryapranata H; Marino P; Luca GD;
    Angiology; 2014 Sep; 65(8):696-702. PubMed ID: 24052525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users.
    Souza FR; Dos Santos MR; Porello RA; Fonseca GWPD; Sayegh ALC; Lima TP; Ferreira FD; Oliveira TF; Yonamine M; Takayama L; Pereira RMR; Negrão CE; Passarelli M; Rochitte CE; Alves MJNN
    Atherosclerosis; 2019 Apr; 283():100-105. PubMed ID: 30826541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
    Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
    Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease.
    Hancock-Cerutti W; Millar JS; Valentini S; Liu J; Billheimer JT; Rader DJ; Cuchel M
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome.
    Hancock-Cerutti W; Lhomme M; Dauteuille C; Lecocq S; Chapman MJ; Rader DJ; Kontush A; Cuchel M
    J Clin Lipidol; 2017; 11(5):1192-1200.e3. PubMed ID: 28826666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease.
    Attia N; Nakbi A; Smaoui M; Chaaba R; Moulin P; Hammami S; Hamda KB; Chanussot F; Hammami M
    Tohoku J Exp Med; 2007 Oct; 213(2):129-37. PubMed ID: 17917406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary artery disease in Taiwanese population.
    Huang YC; Ho CC; Lin PT; Lee BJ; Lai CH; Liaw YP
    Nutr Res; 2010 Jan; 30(1):21-6. PubMed ID: 20116656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.